Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Open in API
Filings indexed 641 across all filing types
Latest filing 2026-03-25 Regulatory Filings
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Observe Medical - Strengthens strategic position in India through an exclusive distribution agreement - Attachment: Observe_Medical_Strengthens_strategic_position_in_India_through_an_exclusive_distrib
Regulatory Filings Classification · 82% confidence The document is a corporate press release announcing an exclusive distribution agreement in India. It does not present financial results, regulatory stress tests, governance rules, or details of a formal shareholder meeting. It is not an annual or interim report, earnings release, call transcript, dividend notice, or capital market transaction. It is a general company announcement about commercial operations, which does not fit any specialized category. Under our taxonomy, such miscellaneous corporate announcements are classified as Regulatory Filings (RNS).
2026-03-25 English
Observe Medical - Strengthens strategic position in India through an exclusive distribution agreement
Regulatory Filings Classification · 70% confidence The document is a corporate press release announcing an exclusive distribution agreement in India. It does not present financial results (not an Earnings Release, Interim Report, or Annual Report), nor is it a capital raise, share transaction, or M&A proposal. It is an operational business update without specific regulatory form references. There is no mention of board changes, dividends, or filings. It therefore does not fit any specialized category and falls into the fallback “Regulatory Filings” category.
2026-03-25 English
Observe Medical - Company presentation with trading update - Attachment: Observe_Medical_ASA_Company_Presentation_trading_update_25_March_2026.pdf
Investor Presentation Classification · 92% confidence The document is titled “Observe Medical Company presentation with trading update” and contains slide-style content: strategic vision, product roadmap, quarterly sales, market data, and forward-looking statements. It is a prepared presentation deck for investors/analysts rather than an official regulatory filing, earnings release, or AGM materials. Therefore, it best fits the Investor Presentation category.
2026-03-25 English
Observe Medical - Company presentation with trading update
Investor Presentation Classification · 88% confidence The document is a company presentation providing a trading update (growth in sales, product launches, market metrics), intended for investors and analysts. It is not a pure earnings release (no headline P&L numbers or EPS), nor just a brief press release; it is clearly an investor presentation (webcast, slides enclosed). Therefore, it fits the Investor Presentation (IP) category.
2026-03-25 English
Innovation Norway financing at NOK 15 million disbursed and dismantling of corporate complexity to further focus on core business
Capital/Financing Update Classification · 95% confidence The document is a corporate announcement detailing a new financing arrangement (NOK 15 million loan from Innovation Norway) and strategic operational changes (dismantling of a subsidiary). It does not constitute a full financial report, but rather an update on capital and corporate structure. Given the focus on financing and business strategy, it fits best under the Capital/Financing Update category.
2026-03-04 English
Observe Medical ASA: Second half and full year interim report - Attachment: Observe_Medical_ASA_Interim_Report_H2_FY_2025.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT H2/FY 2025' and contains comprehensive financial statements, including unaudited condensed consolidated financial statements, key financials, a CEO letter, and a detailed financial review. It covers a period shorter than a full fiscal year (H2/FY 2025) and provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). FY 2025
2026-02-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.